Welcome to our book review site go-pdf.online!

You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.

Sign up

Drug Discovery from Natural Products
  • Language: en
  • Pages: 435

Drug Discovery from Natural Products

An integrated review of the most recent trends in natural products, drug discovery, and key lead candidates that are outstanding for their chemistry and biology in novel drug development.

Antimicrobials
  • Language: en
  • Pages: 363

Antimicrobials

Reports on the emergence and prevalence of resistant bacterial infections in hospitals and communities raise concerns that we may soon no longer be able to rely on antibiotics as a way to control infectious diseases. Effective medical care would require the constant introduction of novel antibiotics to keep up in the “arms race” with resistant pathogens. This book closely examines the latest developments in the field of antibacterial research and development. It starts with an overview of the growing prevalence of resistant Gram-positive and Gram-negative pathogens, including their various resistance mechanisms, prevalence, risk factors and therapeutic options. The focus then shifts to a comprehensive description of all major chemical classes with antibacterial properties, their chemistry, mode of action, and the generation of analogs; information that provides the basis for the design of improved molecules to defeat microbial infections and combat the emerging resistances. In closing, recently developed compounds already in clinical use, those in preclinical or first clinical studies, and a number of promising targets to be exploited in the discovery stage are discussed.

Advances in Pancreatic Cancer
  • Language: en
  • Pages: 226

Advances in Pancreatic Cancer

Pancreatic cancer is a growing source of cancer-related death and has poor survival rates, which have not improved in the last few decades. Its high-mortality rate is attributed to pancreatic cancer biology, difficulty in early diagnosis, and lack of standardized international guidelines in assessing the pancreatic masses. This book aims to provide an update in the current state of play in pancreatic cancer diagnosis and to evaluate the benefits and limitations of the available diagnostic technology and therapy. The main modalities for diagnosis are imaging with HCT, MRI, USE, and PET. Some chapters review the improvements in the techniques used. Timely and accurate diagnosis of pancreatic cancer can lead to improve in the current poor outcome of this disease.

Bergey's Manual of Systematic Bacteriology
  • Language: en
  • Pages: 2102

Bergey's Manual of Systematic Bacteriology

Includes a revised taxonomic outline for the Actinobacteria or the high G+C Gram positives is based upon the SILVA project as well as a description of greater than 200 genera in 49 families. Includes many medically and industrially important taxa.

Defensive Mutualism in Microbial Symbiosis
  • Language: en
  • Pages: 436

Defensive Mutualism in Microbial Symbiosis

  • Type: Book
  • -
  • Published: 2009-05-26
  • -
  • Publisher: CRC Press

Anemones and fish, ants and acacia trees, fungus and trees, buffaloes and oxpeckers--each of these unlikely duos is an inimitable partnership in which the species' coexistence is mutually beneficial. More specifically, they represent examples of defensive mutualism, when one species receives protection against predators or parasites in exchange for

Fungi Bioactive Metabolites
  • Language: en
  • Pages: 759

Fungi Bioactive Metabolites

None

Bioinformatics and Biomedical Engineering
  • Language: en
  • Pages: 697

Bioinformatics and Biomedical Engineering

  • Type: Book
  • -
  • Published: 2017-04-07
  • -
  • Publisher: Springer

This two volume set LNBI 10208 and LNBI 10209 constitutes the proceedings of the 5th International Work-Conference on Bioinformatics and Biomedical Engineering, IWBBIO 2017, held in Granada, Spain, in April 2017. The 122 papers presented were carefully reviewed and selected from 309 submissions. The scope of the conference spans the following areas: advances in computational intelligence for critical care; bioinformatics for healthcare and diseases; biomedical engineering; biomedical image analysis; biomedical signal analysis; biomedicine; challenges representing large-scale biological data; computational genomics; computational proteomics; computational systems for modeling biological processes; data driven biology - new tools, techniques and resources; eHealth; high-throughput bioinformatic tools for genomics; oncological big data and new mathematical tools; smart sensor and sensor-network architectures; time lapse experiments and multivariate biostatistics.

Comprehensive Natural Products II
  • Language: en
  • Pages: 7944

Comprehensive Natural Products II

  • Type: Book
  • -
  • Published: 2010-03-05
  • -
  • Publisher: Elsevier

This work presents a definitive interpretation of the current status of and future trends in natural products—a dynamic field at the intersection of chemistry and biology concerned with isolation, identification, structure elucidation, and chemical characteristics of naturally occurring compounds such as pheromones, carbohydrates, nucleic acids, and enzymes. With more than 1,800 color figures, Comprehensive Natural Products II features 100% new material and complements rather than replaces the original work (©1999). Reviews the accumulated efforts of chemical and biological research to understand living organisms and their distinctive effects on health and medicine Stimulates new ideas am...

Official Gazette of the United States Patent and Trademark Office
  • Language: en
  • Pages: 784

Official Gazette of the United States Patent and Trademark Office

  • Type: Book
  • -
  • Published: 2002
  • -
  • Publisher: Unknown

None

Pharmacoinformatics: New developments and challenges in drug design
  • Language: en
  • Pages: 146

Pharmacoinformatics: New developments and challenges in drug design

Pharmacoinformatics combines bio- and chemoinformatics approaches as well as artificial intelligence to support drug design and development at various stages, starting from preclinical research support to clinical trial design and execution support (stages I, II and III), as well as pharmacovigilance, pharmacoeconomics and personalized medicine. The rational use of these methods, combined with the relevant experimental approaches, is crucial to face the new challenges in drug design and development.